Chronic Obstructive Pulmonary Disease Stocks List

Recent Signals

Date Stock Signal Type
2019-11-13 ADMP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-13 ADMP 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-13 APLS Fell Below 20 DMA Bearish
2019-11-13 APLS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-13 DVAX Stochastic Reached Overbought Strength
2019-11-13 DVAX Crossed Above 200 DMA Bullish
2019-11-13 HZNP New 52 Week Closing High Bullish
2019-11-13 HZNP NR7 Range Contraction
2019-11-13 INGN Calm After Storm Range Contraction
2019-11-13 INGN NR7 Range Contraction
2019-11-13 PULM 50 DMA Support Bullish
2019-11-13 PULM 20 DMA Support Bullish
2019-11-13 PULM Doji - Bearish? Reversal
2019-11-13 PULM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-13 VRNA 50 DMA Support Bullish
2019-11-13 VRNA Hammer Candlestick Bullish
2019-11-13 VRNA 20 DMA Support Bullish
2019-11-13 VTVT Upper Bollinger Band Walk Strength
2019-11-13 VTVT MACD Bullish Centerline Cross Bullish
2019-11-13 VTVT 200 DMA Resistance Bearish
2019-11-13 VTVT Pocket Pivot Bullish Swing Setup

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult. Chronic bronchitis and emphysema are older terms used for different types of COPD. The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years.Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics playing a smaller role. In the developing world, one of the common sources of air pollution is poorly vented heating and cooking fires. Long-term exposure to these irritants causes an inflammatory response in the lungs, resulting in narrowing of the small airways and breakdown of lung tissue. The diagnosis is based on poor airflow as measured by lung function tests. In contrast to asthma, the airflow reduction does not improve much with the use of a bronchodilator.Most cases of COPD can be prevented by reducing exposure to risk factors. This includes decreasing rates of smoking and improving indoor and outdoor air quality. While treatment can slow worsening, no cure is known. COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. Some people may benefit from long-term oxygen therapy or lung transplantation. In those who have periods of acute worsening, increased use of medications and hospitalization may be needed.As of 2015, COPD affected about 174.5 million (2.4%) of the global population. It typically occurs in people over the age of 40. Males and females are affected equally commonly. In 2015, it resulted in 3.2 million deaths, up from 2.4 million deaths in 1990. More than 90% of these deaths occur in the developing world. The number of deaths is projected to increase further because of higher smoking rates in the developing world, and an aging population in many countries. It resulted in an estimated economic cost of $2.1 trillion in 2010.

More about Chronic Obstructive Pulmonary Disease